Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 2
1992 1
1995 1
2000 2
2001 1
2004 1
2005 1
2006 2
2008 1
2009 2
2010 1
2014 3
2015 1
2016 2
2017 2
2019 2
2020 1
2021 2
2022 4
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Epithelial-myoepithelial carcinomas of the bronchus.
Fulford LG, Kamata Y, Okudera K, Dawson A, Corrin B, Sheppard MN, Ibrahim NB, Nicholson AG. Fulford LG, et al. Among authors: okudera k. Am J Surg Pathol. 2001 Dec;25(12):1508-14. doi: 10.1097/00000478-200112000-00006. Am J Surg Pathol. 2001. PMID: 11717540 Review.
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants.
Mizoue T, Yamamoto S, Konishi M, Oshiro Y, Inamura N, Nemoto T, Ozeki M, Horii K, Okudera K, Sugiyama H, Aoyanagi N, Sugiura W, Ohmagari N. Mizoue T, et al. Among authors: okudera k. J Infect. 2022 Nov;85(5):573-607. doi: 10.1016/j.jinf.2022.08.015. Epub 2022 Aug 20. J Infect. 2022. PMID: 35995310 Free PMC article. No abstract available.
Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
Yamamoto S, Maeda K, Matsuda K, Tanaka A, Horii K, Okudera K, Takeuchi JS, Mizoue T, Konishi M, Ozeki M, Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N. Yamamoto S, et al. Among authors: okudera k. Clin Infect Dis. 2022 Aug 24;75(1):e683-e691. doi: 10.1093/cid/ciab1048. Clin Infect Dis. 2022. PMID: 34950947 Free PMC article.
Feasibility and safety of platinum-doublet therapy in patients with small-cell lung cancer in the third-line setting: A multi-institutional retrospective study.
Fukushima T, Makiguchi T, Tanaka Y, Chubachi K, Ishidoya M, Suzuki S, Tanaka H, Taima K, Hasegawa Y, Okudera K, Tasaka S. Fukushima T, et al. Among authors: okudera k. Oncol Lett. 2022 Sep 1;24(4):368. doi: 10.3892/ol.2022.13488. eCollection 2022 Oct. Oncol Lett. 2022. PMID: 36238842 Free PMC article.
Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines.
Nishida N, Sugiyama M, Ohashi J, Kawai Y, Khor SS, Nishina S, Yamasaki K, Yazaki H, Okudera K, Tamori A, Eguchi Y, Sakai A, Kakisaka K, Sawai H, Tsuchiura T, Ishikawa M, Hino K, Sumazaki R, Takikawa Y, Kanda T, Yokosuka O, Yatsuhashi H, Tokunaga K, Mizokami M. Nishida N, et al. Among authors: okudera k. Sci Rep. 2021 Mar 2;11(1):3703. doi: 10.1038/s41598-021-82986-8. Sci Rep. 2021. PMID: 33654122 Free PMC article.
The efficacy of nintedanib in 158 patients with idiopathic pulmonary fibrosis in real-world settings: A multicenter retrospective study.
Dobashi M, Tanaka H, Taima K, Itoga M, Ishioka Y, Shiratori T, Okumura F, Tabe C, Tanaka Y, Morimoto T, Hasegawa Y, Yasugahira H, Okudera K, Takanashi S, Tasaka S. Dobashi M, et al. Among authors: okudera k. SAGE Open Med. 2021 Jun 6;9:20503121211023357. doi: 10.1177/20503121211023357. eCollection 2021. SAGE Open Med. 2021. PMID: 34164129 Free PMC article.
34 results